SLC7A11 and breast carcinoma: (G) SLC7A11 mRNA expression data from the CCLE is shown for breast cancer cell lines reported to be CB-839 resistant (IC50 >1 μM) or CB-839 sensitive (IC50 <1 μM) (Gross et al., 2014).